Loss and Reorganisation of Superficial White Matter in Alzheimer’s disease: A Diffusion MRI study

Introduction

Alzheimer’s disease is characterised by progressive neurodegenerative changes that involve both grey matter (GM) and white matter (WM). Macrostructural GM loss as visualised in hippocampal atrophy using MRI is characteristic of Alzheimer’s disease.^1,2 However, microstructural change may appear before macrostructural neurodegeneration and occur in early stages of the disease.^3–5 Disconnection of neural circuits by means of WM disruption is likely a key driver for cognitive deficits and may be an important pathophysiological process of Alzheimer’s disease.^6,7

WM is heterogeneous and can be broadly divided into superficial white matter (SWM) and deep white matter (DWM).^8,9 SWM mainly consists of short, thin, U-fibres linking nearby gyri that lie up to 2mm below the cortex but may represent 57-67% of all WM fibres.^10–12 SWM fibre organisation is also highly complex^13,14 and may form sub-networks of its own.¹⁵ Unique anatomical, developmental and cellular SWM properties may lead to particular vulnerabilities to Alzheimer’s disease-related pathology. For example, short, thin fibres prevalent in SWM are the last WM outside the cortex to myelinate,^16,17 which means oligodendrocytes in these regions may be more vulnerable to metabolic insults.^18,19 SWM contains the highest density of interstitial cells in WM that harbour neurofibrillary tangles.^20,21 Amyloid-β is also deposited in the SWM of humans and qualitatively associated with focal SWM demylination in mice.^22,23

Although SWM may be vulnerable to Alzheimer’s disease pathology and represents the majority of cerebral WM, relatively few studies have investigated in vivo SWM changes in Alzheimer’s disease. Magnetisation transfer ratio studies sampled at 3mm below the GM/WM boundary found those with Alzheimer’s disease show demyelination in SWM.^24,25 SWM diffusion MRI (dMRI) studies in Alzheimer’s disease and mild cognitive impairment (MCI) have shown increased axial, radial and mean diffusivity (MD) in temporal, parietal and occipital regions that are associated with changes in the Mini Mental State Examination (MMSE) and with increased reaction time on a prospective memory task.^26–29

SWM’s proximity to cortical GM and its complicated fibre organisation present two major methodological challenges that hinder the ability of neuroimaging to localise disease-related changes specific to SWM. Firstly, relatively large dMRI voxel sizes and varying sampling distances below the GM/WM boundary make it unclear whether changes attributed to SWM arise from the cortical GM, SWM or DWM. Secondly, dMRI signal is often modelled using a single tensor that may not capture the organisationally complex microstructure of SWM. Consequently Alzheimer’s disease-related SWM changes in commonly used DTI metrics, such as fractional anisotropy (FA) and MD, may result from a mixture of WM degeneration and reorganisation.³⁰ Therefore, current studies showing Alzheimer’s disease-related changes in SWM may be due to an unknown combination of disease-related effects and confounding methodological issues.

In order to address some of the challenges with quantifying disease-related changes in SWM, we used Neurite Orientation Dispersion and Density Imaging (NODDI) to disentangle neurodegenerative and organisational alterations by independently quantifying the neurite density index (NDI) and orientation dispersion index (ODI) of underlying SWM fibres.³¹ NODDI metrics relate to histological measures of myelin and tau pathology.^32–34 Alzheimer’s disease-related changes in the GM and DWM have also been observed in those with young-onset Alzheimer’s disease.^35,36 The NODDI model also allows separation of free water fraction (FWF) and brain tissue, enabling the removal of the confounding contribution of nearby CSF. We sampled NODDI and DTI measures at various depths along the cortical profile (beginning in cortical GM and descending into the SWM) in 15 a priori cortical regions of interest (ROI) to better understand effects of Alzheimer’s disease on SWM and its neighbouring tissue. We hypothesised that we would replicate significant Alzheimer’s disease-related changes in SWM using standard DTI metrics, and that significant Alzheimer’s disease-related SWM changes would remain when modelling the density and dispersion of neurites using NODDI.

Materials and Methods

Regions of Interest (ROIs) Measures

For each of the four points sampled along the cortical profile, summaries of each dMRI metric were obtained on a region of interest (ROI) level based on anatomical labels from the FreeSurfer Desikan-Killiany atlas brain parcellation. A total of 15 a priori ROIs were included in the analysis. Twelve were chosen from temporal, occipital and parietal regions that are known to be affected in both clinical phenotypes within the young-onset Alzheimer’s disease group (typical Alzheimer’s disease and posterior cortical atrophy)^48,49: entorhinal, superior temporal, fusiform, lateral occipital, middle temporal, posterior cingulate, inferior parietal, parahippocampal, cuneus, inferior temporal, precuneus and superior parietal cortices. Three ROIs in somatosensory cortices, typically spared until later stages of typical Alzheimer’s disease and posterior cortical atrophy,^48,49 were chosen to serve as control ROIs: precentral, postcentral and paracentral cortices. ROI measures for DTI and NODDI metrics were averaged across hemispheres. See Fig. 1 for the full preprocessing pipeline.

• Download figure
• Open in new tab

Figure 1: Schematic of preprocessing pipeline to acquire ROI-level metrics at varying levels from the GM/WM boundary.

a) Structural MRI processing for skull stripping and surface reconstruction to define the GM/WM boundary. b) dMRI processing to create DTI maps (MD and FA) and NODDI maps (NDI, ODI and TF). c) dMRI metrics are sampled at various distances from the GM/WM boundary: GM (1mm outwards in green), GM/WM (on the boundary in yellow), SWM (1mm inwards in red) and SWM/DWM (2mm inwards in blue). d) ROI measures of dMRI metrics, sampled at each distance, are extracted using the Desikan-Killiany atlas from FreeSurfer. ROIs were hypothesised to either be affected (blue) or not affected (yellow) in the young-onset Alzheimer’s disease group.

While NDI and ODI measures are estimated within the TF of each voxel, a conventional ROI average would equally weight NDI and ODI across the region despite varying TF likely to occur near the cortex. Therefore, we used “tissue-weighted” averages of NDI and ODI for all analyses, where TF at corresponding vertices served as the weights.

Statistical Analysis

All statistical analyses were performed using R 3.6.3⁵⁰ and ROI visualisations were plotted using the ggseg package.⁵¹ In addition to plotting individual ROI measures from our main analysis, we averaged the observed dMRI metrics across all 15 a priori ROIs to obtain a composite overview across the four distance points of the cortical profile (Fig. 2).

• Download figure
• Open in new tab

Figure 2: Average observed dMRI metrics (over all a priori ROIs) across the GM/WM boundary for both controls (black) and young-onset Alzheimer’s disease (red) groups.

A) Averaged FA profile shows an increase for both groups when moving into SWM/DWM. B) Average MD profile shows an overall decrease when moving into the SWM/DWM. C) Average NDI profile shows an overall increase when moving into SWM/DWM. D) Average ODI profile shows an overall decrease when moving into SWM/DWM. E) For reference, the average TF profile shows an overall increase when moving into SWM/DWM. Error bars indicate +/- standard deviation across all 15 ROIs, for each group, at each distance from GM/WM boundary. YOAD = Young-Onset Alzheimer’s disease.

Disease-related changes in dMRI metrics along the cortical profile were modelled using linear mixed effect models. A total of 75 models were generated (15 a priori ROIs ×five dMRI metrics). In each model, the outcome variable was the ROI average of the dMRI metric. The model included fixed effects for distance, distance-squared, group (control or young-onset Alzheimer’s disease), average cortical thickness of the ROI, plus interactions between distance and group, and distance-squared and group terms (see Supplementary Material for equation). Quadratic term for distance was used to capture non-linear trends observed when plotting observed data for each ROI (Fig. 2). Cortical thickness was included in the model as a proxy for atrophy and we assumed this would be most associated with diffusion measures in the GM. We therefore set the GM point as the intercept for the model (distance=0), with distance increasing in the direction towards the SWM/DWM (distance=4). Age and sex were not included in the model as they were well balanced in our cohort and including these as covariates produced no meaningful change in results across our models. Group-specific random effects were included for the intercept and slope, along with a covariance term between the intercept and slope. In a small number of models (6/75) where there was difficulty fitting this model, we removed the random slope for the control group (see Supplementary Material). The average marginal effect (AME) of group, at each of the four distance points, was estimated using predicted values from the linear mixed effect models. AMEs represent the estimated difference in the dMRI metric between the young-onset Alzheimer’s disease group compared with controls, using the observed values of other covariates (here, the cortical thickness). Multiple comparisons were corrected for using the False Discovery Rate (FDR), where corrected P-values were considered statistically significant below a threshold of 0.05 (pFDR < 0.05).⁵² Residuals for each model were inspected to check model assumptions were adequately met. We also estimated AMEs across the GM/WM boundary for NODDI measures when using a conventional mean rather than tissue-weighted mean (Supplementary Table 4; Supplementary Fig. 5-6). Example R code for fitting linear mixed effect models and extracting AMEs is included in the supplementary material.

Results

Fig. 2 shows the observed DTI and NODDI metrics averaged across 15 a priori ROIs along the cortical profile. When using DTI metrics, there was an overall increase in FA when moving from the GM into the SWM/DWM (Fig. 2A) and an overall decrease in MD (Fig. 2B) when moving from the GM into the SWM and DWM. When using NODDI metrics, there was an overall increase in NDI when moving from the GM into the SWM/DWM (Fig. 2C) and an overall decrease in ODI when moving from the GM into the SWM/DWM (Fig. 2D). There was an overall increase in TF when moving from GM into SWM/DWM (Fig. 2E).

Group differences, at each of the four distance points across the GM/WM boundary, were then investigated for each ROI (Fig. 3A) and each of the five metrics, using AMEs and their 95% confidence intervals (all reported results significant at pFDR < 0.05). See Supplementary Fig. 1-3 and Supplementary Table 1-3 for all AMEs.

Statistically significant findings across the cortical profile using DTI metrics are shown in Fig. 3B-C. In the SWM (1-2mm below the GM/WM boundary), those with young-onset Alzheimer’s disease had significantly lower FA compared to controls in the parahippocampal (SWM: AME -0.026 [95% CI: -0.039, -0.013]; SWM/DWM: -0.021 [-0.037, -0.005]) and entorhinal SWM (SWM: -0.031 [-0.045, -0.016]), but higher FA within the postcentral SWM (SWM/DWM: 0.028 [0.010, 0.047]). At the GM and on the GM/WM boundary, young-onset Alzheimer’s disease individuals had significantly lower FA in six ROIs: parahippocampal, entorhinal, inferior and superior parietal, lateral occipital cortices and the cuneus (Fig. 3B).

• Download figure
• Open in new tab

Figure 3: Regional group differences along the cortical profile.

A) A priori ROIs were chosen due to prior knowledge of affected areas in young-onset Alzheimer’s disease (blue) or as control ROIs (yellow). Diffusion metrics were obtained along the cortical profile. B-F) DTI, NODDI and TF Average Marginal Effects (AMEs) (pFDR < 0.05) representing the difference in dMRI metric between controls and young-onset Alzheimer’s disease, in each ROI, at each distance across the GM/WM boundary from the linear mixed effect models (GM (1mm outward from GM/WM boundary), GM/WM boundary, SWM (1mm inwards from GM/WM boundary), SWM/DWM (2mm inwards from GM/WM boundary)). Negative AMEs (purple/blue colourmap) indicates a lower dMRI metric in the young-onset Alzheimer’s disease group, while positive AMEs (red/cream colourmap) indicate a higher metric in the young-onset Alzheimer’s disease group. A priori ROIs not coloured in plots have pFDR > 0.05. Supplementary Fig. 4 shows AMEs at uncorrected P < 0.05.

The young-onset Alzheimer’s disease group showed significantly higher MD compared to controls in the parahippocampal SWM (SWM: 0.038 [0.009, 0.067]), but significantly lower MD in the SWM of pre- and postcentral gyri, and the superior temporal region. This contrasts with young-onset Alzheimer’s disease individuals having significantly higher MD across all ROIs in the GM and in all but two ROIs in on the GM/WM boundary (Fig. 3C).

Statistically significant findings across the cortical profile using NODDI metrics are shown in Fig. 3D-E. In the SWM (1-2mm below the GM/WM boundary), individuals with young-onset Alzheimer’s disease had significantly lower NDI in the inferior and superior parietal, precuneus, parahippocampal and entorhinal regions (Fig. 3D). In parietal regions, lower NDI in those with young-onset Alzheimer’s disease was consistent with lower NDI the overlying GM and on the GM/WM boundary, but with no significant group differences were observed within entorhinal, parahippocampal and precuneus GM.

Young-onset Alzheimer’s disease individuals had significantly higher ODI compared to controls in the SWM of the parahippocampal (SWM: 0.020 [0.010, 0.030]; SWM/DWM: 0.016 [0.003, 0.030]), entorhinal (SWM: 0.033 [0.019, 0.048]) and fusiform ROIs (SWM: 0.017 [0.004, 0.030]). This largely contrasted with findings in the GM, where those with young-onset Alzheimer’s disease had significantly lower ODI in widespread regions of GM such as parahippocampal, superior and inferior parietal, middle temporal and posterior cingulate ROIs. On the GM/WM boundary, those with young-onset Alzheimer’s disease also had lower ODI compared to controls in the superior parietal lobe (GM/WM: -0.022 [-0.035, - 0.008]) but significantly higher ODI in the entorhinal ROI (GM/WM: 0.029 [0.016, 0.042]) (Fig. 3E).

We report statistically significant group differences for TF along the cortical profile to provide a reference for DTI and NODDI metric results with respect to macroscopic diffusion changes (Fig. 3F). TF in GM and on the GM/WM boundary was significantly lower in young-onset Alzheimer’s disease compared to controls across all a priori ROIs. TF in SWM remained significantly lower in young-onset Alzheimer’s disease compared to controls, but in fewer ROIs and at a reduced magnitude. TF in SWM/DWM was significantly lower in young-onset Alzheimer’s disease compared to controls in only three ROIs but higher within the superior temporal ROI (SWM/DWM: 0.016 [0.005, 0.026]) (Fig. 3F).

Discussion

In this study we show that 1) NODDI detects disease-related microstructural changes in the SWM of those with young-onset Alzheimer’s disease; 2) these Alzheimer’s disease-related SWM changes do not wholly overlap with DTI metrics; and 3) these microstructural changes vary in their relationship to overlying GM. To our knowledge, this work is both the first to investigate Alzheimer’s disease-related SWM changes using NODDI and to contextualise these findings within the cortical profile of individuals with Alzheimer’s disease.

Our main findings indicate that individuals with young-onset Alzheimer’s disease have reduced NDI in the SWM of parietal, parahippocampal, entorhinal and precuneus SWM but increased ODI in the parahippocampal, entorhinal and fusiform SWM. These effects appear to overlap in some regions (e.g. parahippocampal SWM). However other regions may only detect either a loss of fibres indicated by decreased NDI (e.g. precuneus SWM) (Fig. 3D), or fibre reorganisation indicated by increase ODI (e.g. fusiform SWM) (Fig. 3E). This suggests that myelinated fibres in the SWM undergo both neurodegeneration and reorganisation in young-onset Alzheimer’s disease but that these changes may not always co-localise.

NODDI SWM findings overlap with conventional DTI metrics in regions typically affected early in the disease such as the parahippocampus and entorhinal regions.^53,54 For example, those with young-onset Alzheimer’s disease had lower NDI and FA, but higher MD and ODI, in parahippocampal SWM compared to controls (Fig. 3B-3E). A simultaneous reduction in NDI and increase in ODI here implies FA and MD changes are being driven by both degeneration and reorganisation of WM fibres. These concomitant decreases in FA and NDI with increases in ODI have also been observed in the WM of transgenic mice models of tauopathy that are linked to WM disorganisation.^32,55 Moreover, interstitial cells prevalent in SWM are susceptible to cytoskeletal changes in the entorhinal region and may contribute to these disease-related SWM changes.²⁰

In other regions, NODDI and DTI findings in SWM were not always congruent. Only NDI showed Alzheimer’s disease-related SWM changes in the parietal and precuneus regions, which likely reflects loss of underlying myelinated fibres but may not result in a detectable change of FA,^31,33 potentially due to complex crossing fibres in the underlying SWM.^13–15 A significant increase in ODI alone (e.g. fusiform SWM) indicates increased fibre dispersion in the young-onset Alzheimer’s disease group being the dominating microstructural change, with no statistically significant loss of underlying myelinated fibres. Myelinated fibre disorganisation has also been observed at post-mortem in the cortex of young-onset Alzheimer’s disease individuals⁵⁶ but it is unknown if this extends into SWM.

Conversely, only DTI metrics indicated significant group changes in the superior temporal and central sulcus regions (Fig. 3B-3C). Higher FA and lower MD in young-onset Alzheimer’s disease individuals’ SWM is less clear, but one explanation could be compensatory mechanisms, particularly in regions typically affected by atrophy in later stages such as two of our control regions within the central sulcus. For example, previous FA increases have been observed in asymptomatic amyloid positive individuals⁵⁷ and transgenic mouse models of Alzheimer’s disease prior to intraneuronal plaque accumulation.⁵⁸ Alternatively, previous work has attributed increased anisotropy to a degeneration of crossing fibres and sparing of motor-related projection fibres.⁵⁹ However, with no corresponding NDI or ODI changes in these regions that met our our FDR-corrected threshold for multiple comparisons, the specific microstructural changes driving DTI here are unclear.

Our results do not replicate previous DTI-based findings in the SWM of those with Alzheimer’s disease. Previous studies of Alzheimer’s disease-related changes in SWM found widespread increases in MD,^26,28,29 where our results suggest higher MD in those with Alzheimer’s disease only within the parahippocampal SWM. We also report reduced MD in those with Alzheimer’s disease in the SWM of the central sulcus and superior temporal regions. This could be due to the inclusion of cortical thickness as a covariate in our models, reducing the influence of overlying GM atrophy on SWM metrics (see widespread increased MD in those with Alzheimer’s disease stopping on the GM/WM boundary in Fig. 3C). Taking the NODDI and DTI SWM findings together, NODDI metrics in SWM can detect distinct Alzheimer’s disease-related changes, but together with DTI depict a complex microstructural environment that is likely undergoing spatially heterogeneous pathophysiological affects of Alzheimer’s disease. Further investigation into Alzheimer’s disease-related SWM changes is needed to determine the source of these microstructural effects.

Diffusion metrics also varied when moving along the cortical profile for all participants (Fig. 2). FA increased and MD decreased when moving from GM into SWM, which suggests diffusion in the SWM and DWM is more restricted and anisotropic than in the GM. Kang et al.⁶⁰ also showed increasing FA and decreasing MD in healthy controls and suggested MD values were significantly affected by partial voluming of CSF. Cortical atrophy in the young-onset Alzheimer’s disease group would increase the likelihood of CSF contamination within voxels classified as GM, making it difficult to determine whether changes are entirely due to intrinsic tissue properties from FA and MD alone. Conversely, NODDI metrics allow for the modelling of this partial volume effect with the free water compartment.³¹ While explicitly taking free water into account on the regional level using tissue-weighted averages, NDI increased and ODI decreased when moving from GM into the SWM which provides evidence that changes in FA and MD are partially due to histological features of increased myelination and parallel fibre organisation in WM.

When viewing group effects with NODDI along the cortical profile, young-onset Alzheimer’s disease individuals showed a sustained reduction in NDI in regions such as the precuneus compared to controls, which may indicate reduced density of myelinated neurites in both GM and SWM.³³ Young-onset Alzheimer’s disease individuals showed decreased ODI within GM but increased ODI within certain SWM regions compared to controls. Although most prominent in the parahippocampus, there is a trend of higher ODI in young-onset Alzheimer’s disease individuals across more SWM regions when uncorrected for multiple comparisons (Supplementary Fig. 4). A potential flattening of ODI along the cortical profile suggests neurite organisation could become more similar across the GM/WM boundary in young-onset Alzheimer’s disease and may be associated with blurring of the GM/WM boundary observed in T1w sequences.^61–63

dMRI measures in GM and SWM are likely affected by confounding effects of nearby CSF which is further implicated by GM atrophy in our young-onset Alzheimer’s disease group. We decided to account for CSF partial volume effects using 1) cortical thickness measures within the models for all dMRI metrics and 2) calculating NODDI metrics as tissue weighted averages where TF acted as the weights (where TF = 1-FWF). We also analysed TF changes in order to determine whether macrostructural diffusion changes, likely attributed to the influence of nearby free water in CSF, are occuring simultaneously in these regions across the cortical profile (Fig. 3F). The young-onset Alzheimer’s disease group had lower TF across all GM regions with smaller but significant group differences remaining in the SWM of fewer regions. This suggests that disease-related changes in diffusion tensor metrics in the GM and on the GM/WM boundary are likely to be strongly influenced by free water and partial volume effects. Indeed, striking similarities between MD and TF measures can be observed in the cortical profiles and group differences (Fig. 2B and 2E; Fig. 3C and 3F). Exploratory scatterplots of MD vs TF indicates a prominent negative relationship in the GM and on the GM/WM boundary across all a priori ROIs, but diminishes when entering SWM (Supplementary Fig. 7). Therefore MD findings in the GM and GM/WM boundary may be driven by FWF in the nearby CSF. This suggests previous Alzheimer’s disease-related SWM changes sampled on the GM/WM boundary may be influenced by partial volume effects and supports findings of CSF confounding DTI measures in Alzheimer’s disease that can artificially inflate MD.⁶⁴ Due to SWM’s proximity to the overlying cortical GM we recommend the use of dMRI models that take free water into account, such as NODDI or free-water elimination DTI,^65,66 to allow for more specific insights into pathological microstructural changes.

Nevertheless, when taking taking TF into account using tissue-weighted averages, NDI and ODI still showed disease-related changes in the GM. This complements previous NODDI work in GM of Alzheimer’s disease participants^35,67 by showing Alzheimer’s disease-related reductions in NDI and ODI remain, even when explicitly accounting for the varying degree of FWF within regions. We also provide NODDI results with conventional regional averages as a reference point to previous GM work (Supplementary Fig. 5-6; Supplementary Table 4). Future studies could further overcome CSF and atrophy confounds by studying microstructural GM and SWM changes in individuals at-risk of developing Alzheimer’s disease before macrostructural neurodegeneration occurs.

Varying regional differences in NODDI and DTI metrics may also be due to the spatial distribution of underlying pathology of clinical phenotypes in our young-onset Alzheimer’s disease cohort (typical Alzheimer’s disease and posterior cortical atrophy) in addition to varying SWM properties across regions. For example, atrophy patterns do not completely overlap between typical Alzheimer’s disease (temporo-parietal atrophy) and posterior cortical atrophy (occipito-parietal atrophy),^49,68 while the ability to detect reproducible in vivo SWM fibres using dMRI varies across regions and techniques.⁹ This spatial heterogeneity in both pathology and dMRI’s sensitivity to underlying SWM may obscure our ability to detect underlying microstructural changes. More work is needed to distinguish other contributing factors to in vivo SWM measures and how these would affect potential biomarkers for Alzheimer’s disease.

A limitation of this work is the potential influence of partial volume effects due to the spatial resolution of our dataset (2.5mm isotropic). We opted for a ‘WM mesh’ approach⁹ to determine Alzheimer’s disease-related changes within the SWM region as opposed to extracting specific U-fibre tracts. In addition, we sampled at four points across the GM/WM boundary and modelled the relationship between these points to mitigate misinterpetations of SWM changes. Despite these efforts some influence from partial volume effects will occur. Although U-fibres have been extracted at 1.25mm and 2mm isotropic dMRI resolutions^9,69, submillimetre diffusion MRI greatly improves detection of U-fibres⁷⁰. Indeed, recent advances in submillimetre dMRI enable highly reproducible in vivo U-fibre tracts⁷¹ and the ability to delineate SWM from nearby GM and DWM using iron levels in high-resolution quantitative MRI.¹² This highlights the importance of high-resolution techniques for studying SWM in vivo and evaluating its trade-off with scan duration to determine the clinical applications of SWM-based biomarkers.

Another potential limitation is the role of cortical topography. Curvature of the cortex is known to influence dMRI measures, thus averaging dMRI metrics in an ROI across gyri and sulci could blur and mask true changes. Curvature also varies across brain regions throughout the lifespan and sulcal widening is a prominent feature of macrostructural Alzheimer’s disease changes, which may further contribute to heterogeneous SWM dMRI metrics.^72–74 This could be investigated by segmenting ROIs into curvature-based subregions to determine if SWM measures vary in gyri versus sulci.⁷⁵ Finally, SWM extraction using FreeSurfer is suboptimal as projecting along the surface normal from the GM/WM boundary can produce unrealistic SWM sampling. A recently developed gyral coordinate system that interpolates underlying fibre orientations from gyral morphology has shown to align with primary DTI eigenvectors, and may provide a novel way to investigate in vivo SWM changes in Alzheimer’s disease.⁷⁶

In conclusion, we show that Alzheimer’s disease-related microstructural changes occur within SWM and along the cortical profile. We independently quantified the density and dispersion of underlying SWM neurites using NODDI, two metrics that cannot be disentangled using standard tensor metrics used in previous dMRI studies of SWM in Alzheimer’s disease. For the first time we show lower NDI and higher ODI in the SWM of those with young-onset Alzheimer’s disease, likely due to a loss of myelin and reorganisation respectively. Complex fibres linking nearby gyri in SWM may represent an overlooked region of WM changes in Alzheimer’s disease that could help maximise the usefulness of WM as a neuroimaging biomarker.

Funding

T.V. is funded by an Alzheimer’s Research UK (ARUK) PhD scholarship (ARUK-PhD2018-009). T.P. is supported by an ARUK grant. T.D.P was supported by a Wellcome Trust Clinical Research Fellowship (200109/Z/15/Z). R.W.P is funded by an Alzheimer’s association clinician scientist fellowship, the UK DRI and the Queen Square BRC. D.L.T received funding from the UCL Leonard Wolfson Experimental Neurology Centre (PR/ylr/18575), the UCLH NIHR Biomedical Research Centre, and the Wellcome Trust (Centre award 539208). J.M.S acknowledges the support of the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, ARUK, Brain Research UK, Weston Brain Institute, Medical Research Council, British Heart Foundation and European Union’s Horizon 2020 research and innovation programme. He is an MRC Investigator. N.C.F acknowledges support from the NIHR UCLH Biomedical Research Centre and ARUK. D.M.C is supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK, as well as Alzheimer’s Research UK (ARUK-PG2017-1946) and the UCL/UCLH NIHR Biomedical Research Centre.

Competing Interests

The authors report no competing interests.